Rasio kapitalisasi marang bathi resik uniQure Pharma (QURE)

Lambang korporat lan logo uniQure Pharma (QURE)

uniQure N.V. is optimizing its scientific research by outsourcing formula development and testing to external contractors. The price-to-earnings valuation confirms this strategy, with the indicator currently standing at -7.00. The company relies on a modular AAV platform and its own internal capacities. Growth prospects are tied to transitioning liver and CNS treatments from the trial stage to the market.

uniqure.com (QURE): Rasio rega marang bathi saka 04.07.2022 nganti 16.11.2026

Rincian analitis perusahaan uniQure N.V. (QURE)

- nilai pasar lan prakiraan target analis:
Analisis komprehensif perusahaan:uniQure Corp QURE
Produk asli uniQure Pharma

uniQure N.V. (QURE) achievements in gene therapy and partnerships for hemophilia treatment are reflected in the company's current market P/E ratio, which compares market capitalization to net income. This ratio measures the cost of one dollar of earnings, helping investors determine the degree of asset overvaluation and the risk of purchasing cheap but inefficient securities in an inflationary environment.

Perusahaan pesaing

tempus.com - Kapitalisasi marang bathi resik|Pangali P/E QGEN|Periode bali modal bisnis Isis Pharmaceuticals|Pangali P/E RGEN (repligen.com)|Rasio rega pasar marang bathi resik RNA (Avidity Biosciences, Inc.)|CRSP - Rasio rega marang bathi|Nilai perusahaan marang bathi resik WGS (GeneDx)|RARE: Pangali P/E|Beam Therapeutics Corp - Nilai perusahaan marang bathi resik|Koefisien rega marang bathi SRPT|twistbioscience.com (TWST) - Periode bali modal bisnis|Pangali P/E TXG|NTLA (Intellia) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Stoke STOK|BioLife (BLFS) - Kapitalisasi marang bathi|wavelifesciences.com - Pangali P/E|Kapitalisasi marang bathi resik MAZE|SION: Pangali P/E|PRME - Periode bali modal bisnis|Koefisien rega marang bathi TSHA|Pangali rega marang bathi MGTX (MeiraGTx PLC)|Koefisien rega marang bathi RGNX (regenxbio.com)|Solid Biosciences Inc. - Pangali rega marang bathi|Rasio rega marang bathi Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalisasi marang bathi|BNTC - Rasio rega marang bathi|Design Pharma - Rasio rega pasar marang bathi resik|RCKT (Rocket Pharmaceuticals Inc) - Koefisien rega marang bathi|4D Molecular Therapeutics (FDMT) - Pangali P/E|Rasio rega marang bathi Lexeo Therapeutics, Inc.|Kapitalisasi marang bathi Korro Bio, Inc. KRRO|Pangali P/E EDIT|Periode bali modal bisnis Silence Therapeutics Corp|Rasio rega marang bathi proqr.com PRQR|CDXS - Koefisien rega marang bathi|SGMO - Rasio rega marang bathi|Rasio kapitalisasi marang bathi resik Nautilus Biotechnology, Inc. (NAUT)|MGX: Pangali P/E|Pangali rega marang bathi DTIL|GBIO (Generation Bio) - Pangali P/E|Pangali rega marang bathi BOLD (boundlessbio.com)|Koefisien rega marang bathi XCUR (exicuretx.com)|Celsion Corporation - Pangali rega marang bathi|Pangali P/E PHIO (phiopharma.com)|Pangali P/E Mustang Bio, Inc. MBIO|RNAZ: Koefisien rega marang bathi|BNGO (Bionano Genomics) - Pangali rega marang bathi|APDN: Pangali P/E|bluebird bio (BLUE) - Pangali P/E|Rasio rega marang bathi ImmunoPrecise Antibodies Ltd.|Kapitalisasi marang bathi Omega OMGA|Pangali P/E OMIC|RGLS - Kapitalisasi marang bathi|Syros Pharmaceuticals, Inc - Koefisien rega marang bathi|Periode bali modal bisnis Codex DNA (TBIO)|TCON - Rasio rega marang bathi|UBX: Rasio rega marang bathi